Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

BioXcel Therapeutics (BTAI) Institutional Ownership

BioXcel Therapeutics logo
$1.14 +0.05 (+4.40%)
Closing price 03:59 PM Eastern
Extended Trading
$1.15 +0.02 (+1.41%)
As of 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for BioXcel Therapeutics (NASDAQ:BTAI)

Current
Institutional Ownership
Percentage
30.68%
Number of
Institutional Buyers
(last 12 months)
14
Total
Institutional Inflows
(last 12 months)
$5.22M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$100.38K
Get BTAI Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioXcel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

BTAI Institutional Buying and Selling by Quarter

BioXcel Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026 Millennium Management LLC1,835,192$2.94M0.0%+78.5%8.391%
2/18/2026 Man Group plc56,825$91K0.0%N/A0.260%
2/13/2026 State Street Corp63,218$101K0.0%+19.9%0.289%
2/12/2026 Jane Street Group LLC127,501$204K0.0%N/A0.583%
2/12/2026 HRT Financial LP18,062$28K0.0%N/A0.083%
2/9/2026 Geode Capital Management LLC206,168$330K0.0%+64.6%0.943%
11/17/2025 Millennium Management LLC1,028,053$2.63M0.0%N/A6.421%
11/4/2025 Jones Financial Companies Lllp36,000$97K0.0%+38.5%0.225%
11/3/2025 Foundations Investment Advisors LLC29,549$76K0.0%N/A0.185%
10/23/2025 SLT Holdings LLC29,500$76K0.1%N/A0.184%
8/14/2025 Murchinson Ltd.80,618$146K0.1%-40.8%1.330%
8/14/2025 Diversify Wealth Management LLC15,000$27K0.0%N/A0.248%
8/13/2025 Oaktree Fund Advisors LLC42,913$78K0.1%N/A0.709%
8/13/2025 Oaktree Capital Management LP241,188$437K0.0%N/A3.983%
8/12/2025 XTX Topco Ltd23,424$42K0.0%N/A0.387%
8/8/2025 Geode Capital Management LLC28,182$51K0.0%+27.7%0.465%
6/27/2025 Goldman Sachs Group Inc.24,794$50K0.0%N/A0.409%
5/16/2025Goldman Sachs Group Inc.24,794$50K0.0%N/A0.452%
5/16/2025Murchinson Ltd.136,076$276K0.0%N/A2.480%
2/17/2025Squarepoint Ops LLC72,046$27K0.0%+203.9%0.145%
2/17/2025Millennium Management LLC104,972$39K0.0%-18.5%0.212%
2/14/2025Northern Trust Corp73,910$28K0.0%+81.4%0.149%
2/13/2025Renaissance Technologies LLC77,900$29K0.0%-40.0%0.157%
2/13/2025Wells Fargo & Company MN199,010$74K0.0%+7.5%0.401%
2/12/2025Geode Capital Management LLC311,965$117K0.0%+4.7%0.629%
11/15/2024Jane Street Group LLC49,317$30K0.0%-60.6%0.121%
11/15/2024State Street Corp77,149$47K0.0%-38.2%0.189%
11/13/2024BNP Paribas Financial Markets44,381$27K0.0%-83.8%0.109%
9/16/2024Point72 Asia Singapore Pte. Ltd.30,295$39K0.0%N/A0.081%
8/15/2024Armistice Capital LLC2,987,000$3.82M0.0%+705.2%7.959%
8/15/2024Point72 Asia Singapore Pte. Ltd.30,295$39K0.0%N/A0.081%
8/12/2024XTX Topco Ltd46,503$60K0.0%+49.0%0.124%
7/12/2024Rosalind Advisors Inc.39,672$51K0.0%N/A0.106%
5/20/2024Virtu Financial LLC13,990$39K0.0%-76.5%0.037%
5/10/2024Vanguard Group Inc.1,099,375$3.10M0.0%+0.9%2.968%
2/26/2024Virtu Financial LLC59,514$176K0.0%N/A0.196%
2/14/2024Pennant Investors LP83,900$248K0.1%N/A0.276%
2/13/2024Tower Research Capital LLC TRC13,832$41K0.0%+239.2%0.046%
2/6/2024Apollon Wealth Management LLC10,537$31K0.0%N/A0.035%
2/2/2024Truist Financial Corp10,879$32K0.0%N/A0.036%
SpaceX eyes a 1.75 trillion valuation - here's what to know (Ad)

Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.tc pixel

See how to get positioned in SpaceX before the announcement goes public
1/23/2024DAVENPORT & Co LLC35,385$104K0.0%-42.5%0.118%
12/6/2023Citigroup Inc.24,336$62K0.0%-59.5%0.083%
11/15/2023Adage Capital Partners GP L.L.C.200,000$506K0.0%-89.8%0.683%
11/13/2023FMR LLC2,700,727$6.83M0.0%-38.2%9.227%
10/27/2023Hennion & Walsh Asset Management Inc.33,940$86K0.0%+89.5%0.116%
10/24/2023Bank of New York Mellon Corp128,022$324K0.0%+13.2%0.437%
10/12/2023SeaCrest Wealth Management LLC16,550$42K0.0%-20.0%0.057%
8/14/2023Driehaus Capital Management LLC22,220$148K0.0%-94.3%0.076%
8/11/2023E Fund Management Co. Ltd.10,628$71K0.0%N/A0.036%
8/10/2023Profund Advisors LLC35,475$236K0.0%+29.2%0.122%
8/10/2023US Bancorp DE14,072$94K0.0%+42,542.4%0.048%
8/9/2023BNP Paribas Arbitrage SNC69,994$466K0.0%-38.5%0.240%
7/25/2023Raymond James & Associates18,648$124K0.0%+32.7%0.064%
7/20/2023DAVENPORT & Co LLC59,705$398K0.0%-25.6%0.205%
7/19/2023Artemis Investment Management LLP895,048$5.96M0.1%-8.8%3.069%
7/14/2023SeaCrest Wealth Management LLC20,700$138K0.0%+38.9%0.071%
5/12/2023AlphaCentric Advisors LLC40,000$746K0.5%-20.0%0.138%
5/12/2023SeaCrest Wealth Management LLC14,907$278K0.0%N/A0.051%
5/12/2023Profund Advisors LLC27,462$512K0.0%N/A0.095%
5/11/2023FMR LLC4,276,693$79.80M0.0%+1.7%14.742%
5/11/2023Citigroup Inc.118,975$2.22M0.0%+19,120.5%0.410%
5/10/2023Tocqueville Asset Management L.P.37,000$690K0.0%-6.1%0.128%
5/8/2023Federated Hermes Inc.61,730$1.15M0.0%N/A0.213%
5/8/2023Zurcher Kantonalbank Zurich Cantonalbank12,103$226K0.0%+8.2%0.042%
5/5/2023Truist Financial Corp11,353$212K0.0%-4.9%0.039%
5/5/2023Artemis Investment Management LLP981,472$18.28M0.2%-26.4%3.383%
5/4/2023Barclays PLC56,023$1.05M0.0%+990.8%0.193%
5/4/2023Mirae Asset Global Investments Co. Ltd.14,137$264K0.0%N/A0.049%
4/27/2023DAVENPORT & Co LLC80,295$1.50M0.0%-48.9%0.277%
4/21/2023Capital Investment Advisory Services LLC17,325$323K0.0%N/A0.060%
4/20/2023Hennion & Walsh Asset Management Inc.37,887$707K0.0%-3.3%0.131%
4/14/2023Raymond James & Associates14,052$262K0.0%-11.8%0.048%
4/13/2023Allspring Global Investments Holdings LLC49,311$920K0.0%N/A0.170%
2/14/2023Driehaus Capital Management LLC505,934$10.87M0.2%N/A1.806%
2/10/2023Sectoral Asset Management Inc.61,156$1.31M0.3%N/A0.218%
2/9/2023Tocqueville Asset Management L.P.39,400$846K0.0%+37.5%0.141%
2/8/2023UBS Group AG139,214$2.99M0.0%-2.9%0.497%
2/1/2023Zurcher Kantonalbank Zurich Cantonalbank11,182$240K0.0%+50.0%0.040%
1/25/2023Artemis Investment Management LLP1,333,691$28.75M0.3%-3.0%4.760%
1/20/2023DAVENPORT & Co LLC157,105$3.38M0.0%+44.7%0.561%
1/12/2023Hennion & Walsh Asset Management Inc.39,185$842K0.1%+14.5%0.140%
11/10/2022Connor Clark & Lunn Investment Management Ltd.17,452$206K0.0%N/A0.062%
11/10/2022UBS Group AG143,388$1.70M0.0%+22.5%0.512%
11/9/2022Massachusetts Financial Services Co. MA453,877$5.37M0.0%+7.3%1.620%
11/8/2022AlphaCentric Advisors LLC50,000$591K0.6%N/A0.178%
11/7/2022Quantbot Technologies LP4,879$57K0.0%N/A0.017%
11/7/2022Jump Financial LLC26,000$307K0.0%+22.2%0.093%
10/26/2022Truist Financial Corp23,307$275K0.0%+16.7%0.083%
10/25/2022Artemis Investment Management LLP1,374,496$16.26M0.2%-0.8%4.905%
10/13/2022PVG Asset Management Corp15,040$178K0.7%N/A0.054%
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel

10/11/2022DAVENPORT & Co LLC108,545$1.28M0.0%+26.7%0.387%
8/13/2022Massachusetts Financial Services Co. MA423,021$5.58M0.0%-0.7%1.511%
8/12/2022Virtus ETF Advisers LLC11,284$149K0.1%+46.3%0.040%
8/11/2022Alps Advisors Inc.16,596$219K0.0%-42.3%0.059%
8/8/2022Walleye Capital LLC36,896$487K0.0%N/A0.132%
8/5/2022State Board of Administration of Florida Retirement System17,112$226K0.0%+45.0%0.061%
8/4/2022Game Plan Financial Advisors LLC10,880$142K0.1%N/A0.039%
7/29/2022SG Americas Securities LLC43,468$574K0.0%N/A0.155%
7/29/2022Crossmark Global Holdings Inc.12,083$159K0.0%N/A0.043%
7/22/2022Truist Financial Corp19,974$264K0.0%+3.6%0.071%


BTAI Institutional Ownership - Frequently Asked Questions

During the previous two years, 23 institutional investors and hedge funds held shares of BioXcel Therapeutics. The most heavily invested institutionals were Armistice Capital LLC ($3.82M), Millennium Management LLC ($2.94M), Oaktree Capital Management LP ($437K), Geode Capital Management LLC ($330K), Jane Street Group LLC ($204K), Murchinson Ltd. ($146K), and State Street Corp ($101K).Learn more on BioXcel Therapeutics' institutional investors.

30.68% of BioXcel Therapeutics' stock is owned by institutional investors. Learn more on BTAI's institutional investor holdings.

Of the 21 institutional investors that purchased BioXcel Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($2.62M), Millennium Management LLC ($1.84M), Oaktree Capital Management LP ($241.19K), Murchinson Ltd. ($136.08K), Jane Street Group LLC ($127.50K), Geode Capital Management LLC ($100.97K), and Point72 Asia Singapore Pte. Ltd. ($60.59K).

Institutional investors have bought a total of 2,551,496 shares in the last 24 months. This purchase volume represents approximately $5.22M in transactions.

The following institutional investors have sold BioXcel Therapeutics stock in the last 24 months: Murchinson Ltd. ($55.46K).

Institutional investors have sold a total of 55,458 shares in the last 24 months. This volume of shares sold represents approximately $100.38K in transactions.



This page (NASDAQ:BTAI) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners